IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study

IgG anti-apolipoprotein A-1 (IgG anti-apoA-1) antibodies are present in patients with systemic lupus erythematosus (SLE) and may link inflammatory disease activity and the increased risk of developing atherosclerosis and cardiovascular disease (CVD) in these patients. We carried out a rigorous analy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arthritis research & therapy 2015-02, Vol.17 (1), p.26-26, Article 26
Hauptverfasser:	Croca, Sara, Bassett, Paul, Chambers, Sharon, Davari, Maria, Alber, Karim Fouad, Leach, Oliver, Ioannou, Yiannis, Giles, Ian, Isenberg, David, Rahman, Anisur
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Analysis Apolipoprotein A-I - immunology Apolipoproteins Atherosclerosis Cardiovascular diseases Care and treatment Corticosteroids Development and progression Drug therapy Enzyme-Linked Immunosorbent Assay Female Glucocorticoids - therapeutic use Health aspects Humans Immunoglobulin G Immunoglobulin G - blood Longitudinal Studies Lupus Lupus Erythematosus, Systemic - drug therapy Lupus Erythematosus, Systemic - immunology Lupus Erythematosus, Systemic - mortality Male Medical research Medicine, Experimental Middle Aged Mortality Systemic lupus erythematosus United Kingdom Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!